Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells

Journal of Virology

Volumn 77, Issue 19, 2003, Pages 10606-10622

  Gallego Gómez, Juan Carlos ^a   Risco, Cristina ^a   Rodríguez, Dolores ^a   Cabezas, Pilar ^a   Guerra, Susana ^a   Carrascosa, Jóse L ^a   Esteban, Mariano ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS VACCINE;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFICACY; HELA CELL; HUMAN; HUMAN CELL; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS CORE; VIRUS MORPHOGENESIS; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS STRAIN; WILD TYPE;

ANIMALS; CELL POLARITY; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; CRICETINAE; EPITHELIAL CELLS; HELA CELLS; HUMANS; MICROSCOPY, ELECTRON; MORPHOGENESIS; VACCINIA VIRUS;

EID: 17944400015     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.19.10606-10622.2003     Document Type: Article

References (54)

1. Alcami, A., A. Khanna, N. L. Paul, and G. L. Smith. 1999. Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J. Gen. Virol. 80:949-959.
2. Amara, R. R., J. M. Smith, S. I. Staprans, D. C. Montefiori, F. Villinger, J. D. Altman, S. P. O'Neil, N. L. Kozyr, Y. Xu, L. S. Wyatt, P. L. Earl, J. G. Herndon, J. M. McNicholl, H. M. McClure, B. Moss, and H. L. Robinson. 2002. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. J. Virol. 76:6138-6146.
3. Antoine, G., F. Scheiffinger, F. Dorner, and F. G. Falkner. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365-396.
4. Blanchard, T. J., A. Alcami, P. Andrea, and G. L Smith. 1998. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J. Gen. Virol. 79:1159-1167.
5. Belsham, G. J., J. K. Brangwyn, M. D. Ryan, C. C. Abrams, and A. M. King. 1990. Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease. Virology 176:524-530.
6. Broder, C. C., and P. L. Earl. 1997. Design and construction of recombinant vaccinia viruses. Methods Mol. Biol. 62:173-197.
7. Carroll, M. W., and B. Moss. 1997. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238:198-211.
8. Carroll, M. W., W. W. Overwijk, R. S. Chamberlain, S. A. Rosenberg, B. Moss, and N. P. Restifo. 1997. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model. Vaccine 15:387-394.
9. Can, J., S. Faure, M. Comps, C. Delsert, and N. Morin. 2001. A novel p21-activated kinase binds the actin and microtubule networks and induces microtubule stabilization. J. Cell Biol. 155:1029-1042.
10. Choudhury, S., M. A. el Farrash, M. J. Kuroda, and S. Harada. 1996. Retention of HIV-1 inside infected MOLT-4 cells in association with adhesion-induced cytoskeleton reorganization. AIDS 10:363-368.
11. Coupar, B. E., M. E. Andrew, and D. B. Boyle. 1988. A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene 68:1-10.
12. Dales, S., and L. Siminovitch. 1961. The development of vaccinia virus in Earles L strain cells as examined by electron microscopy. J. Biophys. Biochem. Cytol. 10:475-503.
13. de Jong, E. C., P. L Vieira, P. Kalinski, J. H Schuitemaker, Y. Tanaka, E. A Wierenga, M Yazdanbakhsh, and M. L. Kapsenberg. 2002. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J. Immunol. 168:1704-1709.
14. Earl, P. L., N. Cooper, L. S. Wyatt, B. Moss, and M. W. Carroll. 1998. Titration of MVA stocks by immunostaining, p. 16.9-16.11. In F. M. Ausubel, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene/Wiley Interscience, New York, N.Y.
15. Esteban, M., and C. Patino. 2000. Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS). J. Interferon Cytokine Res. 20:867-877.
16. Flint, S. J., L. W. Enquist, R. M. Krug, V. R. Racaniello, and A. M. Skalka (ed.). 2000. Prevention and control of viral disease, p. 663-714. In Principles of virology: molecular biology, pathogenesis, and control, ASM Press, Washington, D.C.
17. Guerra, S., L. A. López-Fernandez, A. Pacual-Montano, M. Muñoz, K. Harshman, and M. Esteban. 2003. Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 77:6493-6506.
18. Gulley, J., A. P. Chen, W. Dahut, P. M. Arlen, A. Bastian, S. M. Steinberg, K. Tsang, D. Panicali, D. Poole, J. Schlom, and H. J. Michael. 2002. Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer. Prostate 53:109-117.
19. Griffiths, G., N. Ross, S. Schleich, and J. Krijnse-Locker. 2001. Structure and assembly of intracellular vaccinia virus: thin-section analysis. J. Virol. 75:11056-11070.
20. Heljasvaara, R., D. Rodriguez, C. Risco, J. L. Carrascosa, M. Esteban, and J. R. Rodriguez. 2001. The major core protein P4a (A10L gene) of vaccinia virus is essential for correct assembly of viral DNA into the nucleoprotein complex to form immature viral particles. J. Virol. 75:5778-5795.
21. Hollinshead, M., G. Rodger, H. van Eijl, M. Law, R. Hollinshead, D. J. Vaux, and G. L. Smith. 2001. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 154:389-402.
22. Hollinshed, M., A. Vandersplassen, G. L. Smith, and D. J. Vaux. 1999. Vaccinia virus intracellular virions contain only one lipid membrane. J. Virol. 73:1503-1517.
23. Honore, B., P. Madsen, H. H. Rasmussen, J. Vandekerckhove, J. E. Celis, and H. Leffers. 1993. Cloning and expression of a cDNA covering the complete coding region of the P32 subunit of human pre-mRNA splicing factor SF2. Gene 134:283-287.
24. Houhou, L., A. Lamouroux, N. F. Biguet, and J. Mallet. 1995. Expression of human dopamine beta-hydroxylase in mammalian cells infected by recombinant vaccinia virus: mechanisms for membrane attachment. J. Biol. Chem. 270:12601-12606.
25. Joklik, W., and Y. Becker. 1964. The replication and coating of vaccinia DNA. J. Mol. Biol. 10:452-474.
26. Krijnse-Locker, J., A. Kuehn, S. Schleich, G. Rutter, H. Hohenberg, R. Wepf, and G. Griffiths. 2000. Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV. Mol. Biol. Cell 11:2497-2511.
27. Krinje-Locker, J., and G. Griffiths. 1999. An unconventional role for the cytoplasmic disulfide bonds in vaccinia virus proteins. J. Cell Biol. 144:267-279.
28. Mallardo, M., S. Schleich, and L. J. Krijnse. 2001. Microtubule-dependent organization of vaccinia virus core-derived early mRNAs into distinct cytoplasmic structures. Mol. Biol. Cell 12:3875-3891.
29. Moreau, V., F. Frischknecht, I. Reckmann, R. Vincentelli, G. Rabut, D. Stewart, and M. Way. 2000. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2:441-448.
30. Morgan, C. 1976. Vaccinia virus reexamined: development and release. Virology 73:43-58.
31. Moss, B. 2001. Poxviridae: the viruses and their replication, p. 1249-1283. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott/The Williams & Wilkins Co., Philadelphia, Pa.
32. Moss, B., and B. M. Ward. 2001. High-speed mass transit for poxviruses on microtubules. Nat. Cell Biol. 3:E245-E246.
33. Nilsson, C., G. Sutter, L. Walther-Jallow, P. ten Haaft, L. Akerblom, J. Heeney, V. Erfie, P. Bottiger, G. Biberfeld, and R. Thorstensson. 2002. Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques. J. Gen. Virol. 83:807-818.
34. Pearce-Pratt, R., D. Malamud, and D. M. Phillips. 1994. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J. Virol. 68:2898-2905.
35. Perkus, M. E., A. Piccini, B. R. Lipinskas, and E. Paoletti. 1985. Recombinant vaccinia virus: immunization against multiple pathogen. Science 229:981-984.
36. Ramirez, J. C., M. M. Gherardi, and M. Esteban. 2000. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J. Virol. 74:923-933.
37. Risco, C., J. R. Rodriguez, C. Lopez-Iglesias, J. L. Carrascosa, M. Esteban, and D. Rodriguez. 2002. Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly. J. Virol. 76:1839-1855.
38. Risco, C., and J. L. Carrascosa. 1999. Visualization of viral assembly in the infected cell. Histol. Histopathol. 14:905-926.
39. Risco, C., J. R. Rodriguez, W. Demkowicz, R. Heljasvaara, J. L. Carrascosa, M. Esteban, and D. Rodriguez. 1999. The vaccinia virus 39-kDa protein forms a stable complex with the p4a/4a major core protein early in morphogenesis. Virology 265:375-386.
40. Risco, C., M. Muntión, L. Enjuanes, and J. L. Carrascosa. 1998. Two types of virus-related particles are found during transmissible gastroenteritis virus morphogenesis. J. Virol. 72:4022-4031.
41. Rodger, G., and G. L. Smith. 2002. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface. J. Gen. Virol. 83:323-332.
42. Rodriguez, J. F., and G. L. Smith. 1990. Inducible gene expression from vaccinia virus vectors. Virology 177:239-250.
43. Rodriguez, J. R., C. Risco, J. L. Carrascosa, M. Esteban, and D. Rodriguez. 1998. Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes. J. Virol. 72:1287-1296.
44. Rodriguez, D., C. Risco, J. R. Rodriguez, J. L. Carrascosa, and M. Esteban. 1996. Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J. Virol. 70:7641-7653.
45. Rodriguez, D., M. Esteban, and J. R. Rodriguez. 1995. Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J. Virol. 69:4640-4648.
46. Sancho, M. C., S. Schleich, G. Griffiths, and J. Krijnse-Locker. 2002. The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis. J. Virol. 76:8318-8334.
47. Sanderson, C. M., M. Hollinshead, and G. L. Smith. 2000. The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J. Gen. Virol. 81:47-58.
48. Sanderson, C., M. Way, and G. L. Smith. 1998. Virus-induced cell motility. J. Virol. 72:1235-1243.
49. 2+-independent cell-matrix adhesion during the motile phase of infection. J. Virol. 72:9924-9933.
50. Smith, G. L., A. Vandersplasschen, and M. Law. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931.
51. Sodeik, B., R. W. Doms, M. Ericsson, G. Hiller, C. E. Machamer, W. van't Hof, G. van Meer, B. Moss, and G. Griffiths. 1993. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J. Cell Biol. 121:521-541.
52. Sodeik, B., and J. Krijnse-Locker. 2002. Assembly of vaccinia virus revisited: de novo membrane synthesis or acquisition from the host? Trends Microbiol. 10:15-24.
53. Sutter, G., and B. Moss. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89:10847-10851.
54. Tolonen, N., L. Doglio, S. Schleich, and L. J. Krijnse. 2001. Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. Mol. Biol. Cell 12:2031-2046.